Allspring Global Investments
IMVT icon

Allspring Global Investments’s Immunovant IMVT Stock Holding History

Allspring Global Investments’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-60,947
Closed -$1.61M – 2526
2024
Q2 		$1.61M Sell
60,947
-4,144
-6% -$118K ﹤0.01% 1225
2024
Q1 		$2.1M Buy
65,091
+22,226
+52% +$811K ﹤0.01% 1176
2023
Q4 		$1.81M Buy
42,865
+36,659
+591% +$1.35M ﹤0.01% 1202
2023
Q3 		$238K Buy
6,206
+2,228
+56% +$50.4K ﹤0.01% 1718
2023
Q2 		$75.5K Buy
3,978
+2,682
+207% +$50K ﹤0.01% 2159
2023
Q1 		$20.1K Sell
1,296
-11,987
-90% -$208K ﹤0.01% 2498
2022
Q4 		$236K Sell
13,283
-25,384
-66% -$320K ﹤0.01% 1791
2022
Q3 		$215K Sell
38,667
-10,494
-21% -$51.3K ﹤0.01% 1796
2022
Q2 		$191K Buy
+49,161
New +$212K ﹤0.01% 1826

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Allspring Global Investments's IMVT Position: Q3 2024 in Review

Allspring Global Investments sold out of Immunovant (IMVT) in Q3 2024, closing a stake of 60,947 shares — an estimated $1.61M sold.

Allspring Global Investments first reported a position in IMVT in Q2 2022 and held it in 9 quarters. The position peaked at $2.1M in Q1 2024. 181 funds tracked by Wall St. Rank hold IMVT as of Q3 2024.

  • Allspring Global Investments reported no remaining Immunovant position as of Q3 2024 after selling out during the quarter.
  • Allspring Global Investments sold 60,947 Immunovant shares in Q3 2024, an estimated $1.61M.
  • Allspring Global Investments first reported a position in Immunovant in Q2 2022 and held it in 9 quarters.
  • Allspring Global Investments's Immunovant position peaked at $2.1M in Q1 2024.
  • 181 funds tracked by Wall St. Rank held Immunovant as of Q3 2024.

Based on Allspring Global Investments's 13F filing for Q3 2024, filed 18 Oct 2024.